DGAP-News: Medios AG / Key word(s): AGM/EGM
13.07.2018 / 16:54
Medios AG: Successful Annual General Meeting 2018 – High approval of all agenda items
Berlin, 13 July 2018 – Medios AG (‘Medios’), one of the leading Specialty Pharma companies in Germany, has successfully held its 2018 Annual General Meeting today. All agenda items were passed with an approval of almost 100%. Altogether, around 72% of the share capital was present. Besides the discharge of the Management Board and Supervisory Board as well as the election of the auditor for financial year 2018, the 2018 stock option plan including contingent capital, the adjustment of the authorized capital 2018 and the authorization to purchase own shares were adopted. Moreover, the shareholders approved the profit and loss transfer agreements with Medios Digital GmbH, Medios Individual GmbH, Medios Manufaktur GmbH and Medios Pharma GmbH. The complete voting results are available on the company’s website at https://medios.ag/en/investor-relations/general-assembly/.
Matthias Gärtner, CFO of Medios AG: “I would like to thank our shareholders for their continued support and confidence. The strong vote of our investors is giving us tail wind on our way towards becoming the leading Specialty Pharma solutions provider in Germany.”
About Medios AG
Medios AG is Germany’s first listed Specialty Pharma company. The share (WKN: A1MMCC, ISIN: DE000A1MMCC8) is listed in the Regulated Market of the Frankfurt Stock Exchange (General Standard) and Hamburg-Hannover Stock Exchange.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Phone:||+49 30 232 566 – 800|
|Fax:||+49 30 232 566 – 801|
|Listed:||Regulated Market in Frankfurt (General Standard), Hamburg; Regulated Unofficial Market in Dusseldorf|
|End of News||DGAP News Service|